When Can a Thyroid Uptake Scan Be Performed?
A radioactive iodine uptake (RAIU) scan should be performed when the diagnosis of thyrotoxicosis is unclear—specifically when the clinical presentation does not clearly indicate Graves' disease—and nodules do NOT need to be present for the test to be indicated. 1
Primary Indication: Diagnostic Clarification
The RAIU is fundamentally a diagnostic test, not a pre-treatment requirement. According to the 2011 ATA/AACE guidelines, the key indication is diagnostic uncertainty in thyrotoxicosis 1.
When to Order RAIU:
- When diagnosis is uncertain: If a patient doesn't have the classic triad of Graves' disease (symmetrically enlarged thyroid, recent onset ophthalmopathy, and moderate-to-severe hyperthyroidism), order the RAIU 1
- To distinguish uptake patterns: The test differentiates conditions with elevated/normal uptake (Graves' disease, toxic nodular goiter) from those with near-absent uptake (thyroiditis, factitious thyroid hormone ingestion) 1
- Before RAI therapy: While primarily diagnostic, RAIU is necessary before radioactive iodine treatment to calculate the appropriate therapeutic dose 2, 3
When NOT to Order RAIU:
- Classic Graves' disease presentation: Skip the test if diagnosis is clinically obvious 1
- Pregnancy: Absolutely contraindicated 1
- Breastfeeding: Contraindicated 1
Role of Nodules
Nodules are NOT required for RAIU testing. However, when nodules ARE present on examination, a thyroid scan should be added to the uptake measurement 1. This distinction is critical:
- RAIU alone: Measures overall thyroid iodine uptake percentage—useful for all causes of thyrotoxicosis
- RAIU + Scan: When nodularity exists, the scan shows the distribution pattern (diffuse vs. focal uptake), helping distinguish Graves' disease from toxic adenoma or toxic multinodular goiter 1, 4
The 2019 ACR Appropriateness Criteria confirm that ultrasound can identify nodules, and when present on radioactive uptake scan, US should compare findings to identify hypofunctioning or isofunctioning nodules requiring biopsy 4.
Timing Relative to RAI Therapy
The RAIU is performed BEFORE RAI therapy, but it serves dual purposes:
- Diagnostic purpose: Confirms the etiology of hyperthyroidism (high uptake = Graves'/toxic nodular goiter; low uptake = thyroiditis) 1, 4
- Dosimetry purpose: Calculates the appropriate therapeutic RAI dose, particularly important for toxic nodular goiter and autonomous nodules 5, 2
The 2022 French consensus emphasizes that dosimetric methods using iodine uptake measurements should ideally be preferred over fixed-dose approaches, following the ALARA principle 5.
Common Pitfalls to Avoid
- Recent iodine exposure: RAIU may be falsely low after iodinated contrast (1-2 months), amiodarone, or iodine-rich diets (seaweed, kelp). Consider urinary iodine measurement if exposure suspected 1
- Assuming nodules are required: Many clinicians mistakenly believe RAIU requires nodular disease—it doesn't 1
- Ordering for hypothyroidism: There is NO role for RAIU in hypothyroidism workup—all causes show decreased uptake 4
Alternative When RAIU Contraindicated
When RAIU cannot be performed (pregnancy, breastfeeding, recent iodine exposure), alternatives include: